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Abstract  
Pharmacogenetics is one of the factors that effect on drug  response and for the important of this subject, the 
study researched the correlation between the blood group and therapeutic response in infertile patients who are 
treated by pregnyl. 
Forty  patients of different blood groups subdivide to four groups each one composed of ten patients of the same 
blood type as follow ten patients of blood group A, ten of B, ten of AB and ten of blood group O. From each 
patient collected two seminal samples one before treatment and the other after three months of treatment and 
analyze the seminal fluid to detect sperm concentration.   
Result: the paper show the patients of blood group O are more response (increase sperm concentration) compare 
with other blood groups while those of group AB not significantly response, patients with blood group A are 
significantly response ( p<0.05) (increase sperm concentration) and those with blood group B are also significant 
(p<0.05)  but by lesser degree than group A. There is relationship between blood group and treatment response.    




spermatogenesis (sperm production) is a very orchestrated and complex biological process occur in epithelium of 
seminiferous tubule which is testicular functional unit, that produces in a human male at puberty higher than 100 
million of sperms in each day(1). 
Spermatogenesis take place in the testicles as a series of harmonized steps(2). Spermatogonial germ cells situated 
on the basal membrane of seminiferous tubules which suffer either self-regeneration or mitotic divide to produce 
primary sperm cell and these cells suffer first meiotic divide to produce secondary spermatocytes, and then 
undergo a second meiotic divide to give four haploid, round shaped spermatids. Development and elongate will 
be occur during the spermiogenesis to form a mature spermatozoa. During the spermiogenesis, the acrosome is 
forming at one of poles of spermatid to compose sperm head, and  flagellum extends from the other pole and, 
after that, elongates to compose the tail(2).  
1.1.1 Hormonal control of spermatogenesis 
Spermatogenesis process take place under the control of stromal cell and steroidal hormones. The types of 
somatic cell  which play supporting role in spermatogenesis are Leydig cells and Sertoli cells. Sertoli cells 
located on basal membrane which are important for germ cell to get the hormones, nutrients and other molecules 
which are essential to sperm maturation. While Leydig cells located between seminiferous tubules, these cells 
release androgen steroidal hormones(1,3). 
While the hormonal regulation occur by luteinizing hormone (LH) and follicle-stimulating hormone (FSH) 
which are secreted by the pituitary under the effect of gonadotropin releasing hormone which are secreted by the 
hypothalamus, also controlled by estradiol-17β and testosterone that formed locally by testis which are important 
in regulation (feedback loop), in axis of hypothalamic-pituitary-testicular (4). 
Follicle-stimulating hormone practiced its influences on cells of Sertoli to cause stimulation, maturation and 
maintain of spermatogenesis by follicle-stimulating hormone receptors which are limited to the cells of Sertoli  
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in the mammals(5). While luteinizing hormone binds to its receptors found in cells of Leydig  to produce of 
testosterone, that is the main hormone supporting adult spermatogenesis(3,6-9).       
 
1.2: Blood group 
A complete blood type would describe a full set of 30 substances on the surface of RBCs, and an individual’s 
blood type is one of many possible combinations of blood group antigens(10). Almost always, the person's retains 
the same blood group lifetime, but very rarely an individual’s blood type changes(11,12). One of the most common 
cause in blood type change is a bone marrow transplant for treatment some disease for example in leukemia. If a 
person receives bone marrow from someone who is a different ABO type (e.g., a type A patient receives a type 
O bone marrow), the patient’s blood type will eventually converted to the donor’s type. 
A blood group is a classification of blood depend on the presence or absence of inherited antigenic materials on 
the surface of red blood cells (RBCs). These antigens may be proteins, carbohydrates, glycoproteins, or 
glycolipids. Several of these antigens can stem from one allele (or an alternative version of a gene) and 
collectively form a blood group system(13).  Blood types are inherited and represent contributions from both 
parents. A total of 33 human blood group systems are now recognized by the International Society of Blood 
Transfusion (ISBT) (14).  The most  important two are ABO and the RhD antigen; they determine someone’s 
blood type (A, B, AB and O, with +, − or Null denoting RhD status). 
The ABO system is the most important blood-group system in human-blood transfusion. According to this 
system blood groups divided to A,B, AB and O. 
The immune system forms antibodies against whichever ABO blood group antigens are not found on the 
individual's RBCs. Thus, a group A individual will have anti-B antibodies and a group B individual will have 
anti-A antibodies. Blood group AB is the least common, and these individuals will have neither anti-A nor anti-B 
in their serum. Blood group O is common, and individuals with this blood type will have both anti-A and anti-B 
in their serum(15). 
The Rhesus system (Rh) is the 2nd most significant blood-group system in human-blood transfusion with 
currently 50 antigens. The most important Rh antigen is the D antigen, due to it is the most likely to stimulate an 
immune system response of the five main Rh antigens. It is common for D-negative persons not to have any anti-
D IgG or IgM antibodies, due to anti D antibodies are not usually produced by sensitization against 
environmental materials. However, D-negative persons can produce IgG anti-D antibodies after a sensitizing 
event: possibly a fetomaternal transfusion of blood from embryo in pregnancy or occasionally a blood 
transfusion with D positive RBCs (16).  The presence or absence of the Rh(D) antigen is signified by the + or − 
sign, so that for example the A− group is ABO type A and does not have the Rh (D) antigen. 
1.3: Pregnyl 
Is a trade name of Human chorionic gonadotropin (hCG) which is a glycoprotein produced at high 
concentrations by the trophoblasts of the placenta(17).  
HCG consisting of an α and β subunits. The α subunit belongs  to the  glycoproteins hormone (GPH) family that 
also includes luteinizing hormone (LH) and follicle stimulating hormone (FSH)(18). The β subunit is unique to 
each glycoprotein and bestows the specificity of the hormone (19).  
HCG and LH give the same activity, that is, they motivate the production of testosterone in the testicles of males 
and progesterone and estradiol in the female ovaries(20). HCG is utilized as a treatment for male infertility. hCG 
stimulates the Leydig cells of the testes by binding to the LH/CG receptors producing testosterone and triggering 
sperm production. The LH receptor is also present in a large number of tissues other than the ovary and thus 
hCG (and LH) may have hitherto unknown functions(21,22). 
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Material and Method  
2.1: patients 
Forty patients divided to four groups depending on their blood group (ABO), (10 patients of A, 10 = B , 10 = 
AB, 10 = O) after the investigation test to sure the blood group by pull of two mL of blood from the antecubital 
vein with antiseptic measures of each subject in a disposable syringe, and transferred immediately to a tube 
containing ethylene diamine tetra acetic acid (EDTA). Blood grouping (ABO) and Rhesus factors (Rh) was done 
by the antigen antibody agglutination test. 
2.2: Seminal fluid analysis (SFA) 
Samples were obtained from 40 male patients of 20 - 45 years of age attending fertility center in AL-sader 
medical city(both primary and secondary infertility cases). All specimens were collected into clean, dry, sterile 
plastic containers by masturbation after an abstinence period of 3-5 days and were analyzed within 1h of 
collection. After allowing at least 30 min for liquefaction to occur, semen analysis was performed to measure 
sperm concentration, normal sperm morphology and percentage sperm motility. The container labeled with the 
necessary information including name and age, file number, abstinence period and time of sample collection. 
Macroscopic and microscopic examinations were performed according to WHO methodology mentioned in 
details in WHO manual(23). The SFA down before start the treatment and after three months of treatment.   
Results  
The response of the patients to the therapy appear variable depend on the blood group of the patient and as seen 
in the table (1) and figure (1) the average of sperm concentration ( million/ml ) in blood group O is markedly 
increased after three month of treatment ( P < 0.002 compared with before: t-test ). Patients, with blood group A 
shown a relatively less increase in sperm concentration compared with group O but it significant ( p < 0.039 ). 
While those with blood group B also appear significant rise ( p< 0.046). Only the patients of blood group AB 
give simplest alteration in sperm concentration by the pregnyl used in the study which is non-significant.  
From table (2) and figures (2,3,4 and 5) there is correlation between blood groups and the response infertile male 
to pregnyl where vary from very good response to blood group O for good response to group A and then group B 
and the last one is blood group AB. 
Discussion 
The difference in blood group associated with variation of percentage of occurrence the disease among the 
persons as for example, The persons of blood group A are more susceptible for cardio-vascular diseases, 
atherosclerosis, peripheral vascular diseases and many other cardio vascular diseases compared to non A types, 
especially the O types. Other example, The infertility is more distributed in persons of blood type O followed by 
B then A(24). Also this difference in blood group may be associated with difference in pharmacogenetics. 
During the last years, begin speak about the role and the effect of pharmacogenetics in medication response and 
appear the adverse effects. Where there are individual differences between one person and another. Worked large 
number of studies to cover this field and these research studied the input of genetic factor in contrast between the 
patients in both safety and efficacy of the drug. Example of pharmacogenetics, During second World War, was 
noticed the antimalarial medication (primaquine) was accompanied by acute hemolytic crises especially in Afro-
American army, and is rarely at Caucasian army. After period, it was found that this occur by a genetically 
determined lack of glucose-6-phosphate dehydrogenase, which altered red blood cells metabolism(25,26). That's 
what encouraged me to study the relationship between response to therapy and  blood group in infertile patient. 
As show in this study the  infertile males of blood group AB non-significant  respond to pregnyl in standard 
regimen while patients with blood group O are significantly respond to treatment where there is good increase in 
sperm concentration from 7760000 to 12650000 (million/ml) as average ( p<0.05; N=10 ) while  the patients 
with blood group A in the second place in therapeutic response and those with blood group B are also 
significantly respond but by lesser degree.  From these results can be suggest there is correlation between blood 
group and drug response. 
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This relationship between treatment response and blood group genetically may be mostly come from two 
different ways, either from genetic factors influence on pharmacokinetic of the drug especially on the 
metabolism by increase it  and this lead to decrease drug plasma level, result in weak or no effect, and that may 
we need to increase the dose to resolve this problem and give good effect or use alternative drug.  
The metabolism of certain drugs is depend on the amount and kind of functional alleles for some genes which 
are carries by a person. These genes more common encoded the cytochrome-P enzymes. The metabolizer type 
can be divided to poor metabolizers (applied to describe the persons with slight or without functional activity of 
a selected cytochrome-P enzyme), intermediate metabolizers, extensive metabolizers and ultrarapid 
metabolizers. according to the kind of cytochrome-P variation existent, the therapeutic medication response is 
predominatingly variable. For example, poor metabolizers mean are failure to metabolize some drugs worthily, 
result in accumulation of the drug in the body and reach to toxic level. while in case of ultrarapid, the active drug 
convert to inactive quickly, lead to less treatment response(27). 
FSH receptor (FSHR), which is present exclusively on the membrane of granulosa cells, plays an essential role 
in mediating FSH action, thereby inducing folliculogenesis(28, 29). It has been observed that reduced presence of 
this receptor on granulosa cells may account for poor influence on ovarian response to FSH in female 
undergoing IVF treatment. The findings suggest that increasing the dose of exogenous FSH does not get better 
oocyte development probably due to insufficiency of receptor expression on granulosa cells(30). A number of 
normally occurring inactivate mutations in the receptor gene it has been reported in subjects with infertility. The 
phenotype of the infertile subjects has been well correlated with the extent of FSHR inactivation (28, 31). Besides 
inactivating mutations, several single-nucleotide polymorphisms was diagnosed in the receptor coding region. 
where a significant relation between FSHR gene polymorphisms and ovarian response has been reported in 
subjects undergoing IVF treatment(32, 33). 
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Pair 1 Before A & After A 10 0.950 0.000 
Pair 2 Before B & After B 10 0.813 0.004 
Pair 3 Before AB & After AB 10 0.777 0.008 
Pair 4 Before O & After O 10 0.959 0.000 
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Figure-2 : Correlation between drug response and blood group A. 
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Figure-4 : Effect of the drug on sperm concentration in blood group AB. 
Journal of Biology, Agriculture and Healthcare                                                                                                                                www.iiste.org 
ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) 




Figure-5: Clear significant correlation between drug response and blood group O.  
 
The IISTE is a pioneer in the Open-Access hosting service and academic event management.  
The aim of the firm is Accelerating Global Knowledge Sharing. 
 
More information about the firm can be found on the homepage:  
http://www.iiste.org 
 
CALL FOR JOURNAL PAPERS 
There are more than 30 peer-reviewed academic journals hosted under the hosting platform.   
Prospective authors of journals can find the submission instruction on the following 
page: http://www.iiste.org/journals/  All the journals articles are available online to the 
readers all over the world without financial, legal, or technical barriers other than those 
inseparable from gaining access to the internet itself.  Paper version of the journals is also 
available upon request of readers and authors.  
 
MORE RESOURCES 
Book publication information: http://www.iiste.org/book/ 
Academic conference: http://www.iiste.org/conference/upcoming-conferences-call-for-paper/  
 
IISTE Knowledge Sharing Partners 
EBSCO, Index Copernicus, Ulrich's Periodicals Directory, JournalTOCS, PKP Open 
Archives Harvester, Bielefeld Academic Search Engine, Elektronische Zeitschriftenbibliothek 
EZB, Open J-Gate, OCLC WorldCat, Universe Digtial Library , NewJour, Google Scholar 
 
 
